- The ubiquitin–proteasome system (UPS) is the principal mechanism by which eukaryotic cells selectively degrade proteins to maintain homeostasis and regulate essential biological processes. By tagging proteins with ubiquitin and directing them to the proteasome for destruction, the UPS ensures precise control over protein abundance, quality, and turnover. This selective degradation influences cell‑cycle progression, signal transduction, transcriptional regulation, immune responses, and stress adaptation. Because of its central role in maintaining protein balance, the UPS is a cornerstone of cellular regulation and modern molecular biology.
- The UPS operates through two coordinated components: ubiquitin, a small regulatory protein, and the 26S proteasome, a large multi‑subunit protease complex. Proteins destined for degradation are first modified by the attachment of ubiquitin molecules through an enzymatic cascade involving E1 (activating), E2 (conjugating), and E3 (ligating) enzymes. E3 ligases provide substrate specificity, determining which proteins are marked for destruction. Once a protein is polyubiquitinated, the ubiquitin chain acts as a molecular signal that directs it to the proteasome, where it is unfolded and degraded into small peptides.
- The UPS plays a vital role in cell‑cycle regulation. Cyclins and other regulatory proteins are degraded at specific times to ensure orderly progression through G1, S, G2, and M phases. The anaphase‑promoting complex/cyclosome (APC/C), an E3 ligase, targets mitotic cyclins for degradation, enabling exit from mitosis. This controlled destruction prevents premature cell‑cycle transitions and maintains genomic stability. The UPS therefore acts as a molecular timer that coordinates cell division with cellular needs.
- In signal transduction, the UPS modulates the duration and intensity of signalling pathways by degrading activated receptors, transcription factors, and kinases. For example, the NF‑κB pathway is tightly regulated by UPS‑mediated degradation of its inhibitor, IκB. Similarly, the UPS terminates growth factor signalling by removing phosphorylated receptors from the cell surface. These regulatory events ensure that signals are transient and appropriately integrated into cellular responses.
- The UPS also contributes to DNA damage repair. Ubiquitination and deubiquitination of histones and repair factors regulate chromatin accessibility and recruitment of repair machinery. By controlling the stability of proteins involved in homologous recombination and non‑homologous end joining, the UPS maintains genomic integrity. Disruption of UPS‑mediated repair can lead to mutations, chromosomal instability, and disease.
- In immune regulation, the UPS generates antigenic peptides that are presented on MHC class I molecules, enabling recognition of infected or abnormal cells. It also modulates inflammatory signalling by controlling the turnover of key adaptor proteins. These functions highlight the UPS as a central player in both innate and adaptive immunity.
- Dysregulation of the UPS has severe consequences. Impaired proteasome activity leads to accumulation of misfolded or toxic proteins, contributing to neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and Huntington’s disease. In cancer, altered ubiquitination or proteasome function promotes uncontrolled cell growth by stabilising oncogenic proteins. As a result, UPS components are major therapeutic targets. Proteasome inhibitors, such as bortezomib, are used in cancer treatment, while emerging technologies like PROTACs exploit the UPS to selectively degrade disease‑associated proteins.
- Overall, the ubiquitin–proteasome system is an essential regulator of cellular physiology. Its ability to selectively recognise, tag, and degrade proteins ensures precise control over countless biological processes. Understanding UPS‑mediated regulation provides valuable insight into disease mechanisms, therapeutic strategies, and the fundamental principles of protein homeostasis.
